Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$72.62 - $150.62 $529,181 - $1.1 Million
-7,287 Reduced 38.21%
11,786 $1.78 Million
Q1 2024

May 13, 2024

SELL
$70.86 - $89.93 $352,315 - $447,131
-4,972 Reduced 20.68%
19,073 $1.41 Million
Q4 2023

Feb 13, 2024

SELL
$36.74 - $81.08 $209,858 - $463,128
-5,712 Reduced 19.2%
24,045 $1.9 Million
Q3 2023

Nov 14, 2023

SELL
$53.47 - $96.07 $252,645 - $453,930
-4,725 Reduced 13.7%
29,757 $1.63 Million
Q2 2023

Aug 11, 2023

SELL
$66.23 - $88.73 $12,981 - $17,391
-196 Reduced 0.57%
34,482 $2.9 Million
Q1 2023

May 12, 2023

SELL
$53.63 - $82.33 $1.97 Million - $3.02 Million
-36,710 Reduced 51.42%
34,678 $2.63 Million
Q4 2022

Feb 24, 2023

BUY
$39.08 - $64.29 $1.39 Million - $2.29 Million
35,675 Added 99.89%
71,388 $4.41 Million
Q4 2022

Feb 13, 2023

SELL
$39.08 - $64.29 $50,139 - $82,484
-1,283 Reduced 3.47%
35,713 $2.2 Million
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $273,814 - $483,687
8,676 Added 30.64%
36,996 $1.62 Million
Q2 2022

Aug 12, 2022

BUY
$20.56 - $32.15 $582,259 - $910,488
28,320 New
28,320 $860,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.15B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.